 | • レポートコード：MRC2205A091 • 出版社/出版日：Transparency Market Research / 2022年4月30日 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界の冠動脈ステント市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品種類別（ベアメタルステント、薬剤溶出性ステント、生体吸収性ステント）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の冠動脈ステント市場規模：製品種類別（ベアメタルステント、薬剤溶出性ステント、生体吸収性ステント） ・世界の冠動脈ステント市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Coronary Stents Market – Scope of Report
TMR’s report on the global coronary stents market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global coronary stents market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global coronary stents market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global coronary stents market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global coronary stents market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global coronary stents market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global coronary stents market.
The report delves into the competitive landscape of the global coronary stents market. Key players operating in the global coronary stents market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global coronary stents market that have been profiled in this report.
Key Questions Answered in Coronary Stents Market Report
What is the scope of growth of product companies in the global coronary stents market?
What will be the Y-o-Y growth of the global coronary stents market between 2017 and 2028?
What is the influence of changing trends in technologies on the global coronary stents market?
Will North America be the most profitable market for coronary stents providers?
Which factors are anticipated to hamper the growth of the global coronary stents market during the forecast period?
Which are the leading companies in the global coronary stents market?
Research Methodology
TMR has utilized a unique research methodology to conduct a comprehensive research on the growth of the global coronary stents market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global coronary stents market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the coronary stents market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the coronary stents market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global coronary stents market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global coronary stents market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Coronary Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Coronary Stents Market Analysis and Forecast, 2017–2028
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemics Impact on Industry
6. Global Coronary Stents Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2028
6.3.1. Bare Metal Stents
6.3.2. Drug Eluting Stents
6.3.3. Bio-absorbable Stents
6.4. Market Attractiveness Analysis, by Product Type
7. Global Coronary Stents Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region
8. North America Coronary Stents Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Product Type, 2017–2028
8.2.1. Bare Metal Stents
8.2.2. Drug Eluting Stents
8.2.3. Bio-absorbable Stents
8.3. Market Value Forecast, by Country, 2017–2028
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Product Type
8.4.2. By Country
9. Europe Coronary Stents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017–2028
9.2.1. Bare Metal Stents
9.2.2. Drug Eluting Stents
9.2.3. Bio-absorbable Stents
9.3. Market Value Forecast, by Country/Sub-region, 2017–2028
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Product Type
9.4.2. By Country/Sub-region
10. Asia Pacific Coronary Stents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2028
10.2.1. Bare Metal Stents
10.2.2. Drug Eluting Stents
10.2.3. Bio-absorbable Stents
10.3. Market Value Forecast, by Country/Sub-region, 2017–2028
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Product Type
10.4.2. By Country/Sub-region
11. Latin America Coronary Stents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2028
11.2.1. Bare Metal Stents
11.2.2. Drug Eluting Stents
11.2.3. Bio-absorbable Stents
11.3. Market Value Forecast, by Country/Sub-region, 2017–2028
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Product Type
11.4.2. By Country/Sub-region
12. Middle East & Africa Coronary Stents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2028
12.2.1. Bare Metal Stents
12.2.2. Drug Eluting Stents
12.2.3. Bio-absorbable Stents
12.3. Market Value Forecast, by Country/Sub-region, 2017–2028
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Product Type
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player – Competition Matrix (by tier and size of companies)
13.2. Market Share Analysis, by Company, 2020
13.3. Company Profiles
13.3.1. Abbott Laboratories
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Analysis
13.3.1.3. Growth Strategies
13.3.1.4. SWOT Analysis
13.3.2. Boston Scientific Corporation
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Analysis
13.3.2.3. Growth Strategies
13.3.2.4. SWOT Analysis
13.3.3. Medtronic, Inc.
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Financial Analysis
13.3.3.3. Growth Strategies
13.3.3.4. SWOT Analysis
13.3.4. Johnson & Johnson
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Financial Analysis
13.3.4.3. Growth Strategies
13.3.4.4. SWOT Analysis
13.3.5. Terumo Corporation
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Analysis
13.3.5.3. Growth Strategies
13.3.5.4. SWOT Analysis
13.3.6. B. Braun Melsungen AG
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Analysis
13.3.6.3. Growth Strategies
13.3.6.4. SWOT Analysis
13.3.7. C. R. Bard, Inc.
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Analysis
13.3.7.3. Growth Strategies
13.3.7.4. SWOT Analysis
13.3.8. Cook Medical, Inc.
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Financial Analysis
13.3.8.3. Growth Strategies
13.3.8.4. SWOT Analysis
13.3.9. AMG International GmbH
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Financial Analysis
13.3.9.3. Growth Strategies
13.3.9.4. SWOT Analysis
13.3.10. Biotronik SE & Co. KG
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Financial Analysis
13.3.10.3. Growth Strategies
13.3.10.4. SWOT Analysis
13.3.11. Stentys SA
13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.11.2. Financial Analysis
13.3.11.3. Growth Strategies
13.3.11.4. SWOT Analysis
13.3.12. MicroPort Scientific Corporation
13.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.12.2. Financial Analysis
13.3.12.3. Growth Strategies
13.3.12.4. SWOT Analysis